Clin2
NCT06722469Likely a fitNot yet recruiting

Chatbot to increase breast cancer screening

Breast Cancer PreventionBreast Cancer Risk

Part of Cancer, Skin clinical trials.

This study tests whether a chatbot can help Chinese women get breast cancer screening. It is for women who are at average risk and have not been screened yet.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
470 people
Ages
44 years to 69 years
Study type
Interventional

Who can take part

  • You are a Chinese woman
  • You are between 44 and 69 years old
  • You are eligible to join a government-supported breast cancer screening program
  • You can read Chinese
  • You are not already considered at moderate or high risk for breast cancer by the screening program

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07029490Recruiting
Study to improve mammogram outreach for underserved groups

This trial tests a program to help people who face barriers get routine mammograms. If you are going for a regular breast cancer screening, you may be able to join.

Salt Lake City, Utah
NCT07741266Not yet recruiting
Chatbot support for fertility concerns after cancer

This trial tests a chatbot that provides information and support about fertility concerns to young women who have had cancer. It aims to help them feel more in control and less worried about their reproductive health.

Hefei, Anhui
NCT06943911Not yet recruiting
AI chatbot support for Arabic-speaking women with breast cancer

This trial tests whether an AI chatbot can help women with breast cancer by providing information and support. You may join regardless of your cancer stage if you can use the chatbot in Arabic.

Cairo
NCT05286034Recruiting
AI chatbot to help women join cervical screening

This trial tests whether an AI chatbot can encourage women to take part in cervical cancer screening. It targets women who have not had a recent Pap test and who did not respond to an invitation letter, aiming to improve participation.

Carcassone
NCT05562778Recruiting
Chatbot helps you complete hereditary cancer genetic risk testing

This study tests whether a chatbot can help people complete hereditary cancer genetic risk assessment before a gynecology new-patient visit. It may help you understand and organize next steps for genetic testing, if needed.

Brooklyn, New York
NCT07719062Not yet recruiting
AI chatbot for prostate radiation education

This trial tests an AI chatbot designed to help educate patients about prostate cancer radiation therapy. It may provide a simple way to answer your questions before treatment.

Hear when a new Breast Cancer Prevention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.